Matthias Mann, director of the Max Planck Institute of Biochemistry, has been awarded the 2012 Korber European Science Prize for his work in proteomics.
The prize, which will be present on Sept. 7, comes with a €750,000 ($940,000) award.
BG Medicine said in an SEC filing that Pieter Muntendam has resigned from his posts as executive VP and chief medical officer to pursue other opportunities. Muntendam was the company's CEO for six years before he left that post early this year and was replaced by Eric Bouvier.
The company also said that at its annual stockholder meeting this week it re-elected three members of its board of directors: Noubar Afeyan, Stelios Papadopoulos, and Harrison Bains.
The Institute for Systems Biology has appointed Robert Lipshutz to be chief business officer and senior VP for strategic partnerships.
Lipshutz spent nearly two decades at Affymetrix in various roles focusing on business development, licensing, diagnostics, and emerging markets, and most recently as senior VP for corporate development.
Molecular diagnostic company Crescendo Bioscience has tapped Oscar Segurado to be chief medical officer, David Chernoff to be senior VP of medical affairs, and Rebecca Bolce as director of medical affairs.
Segurado will oversee growth and clinical development of Vectra DA, the company's test for RA disease and R&D for other auto-immune and inflammatory tests. He most recently was VP of clinical development and medical affairs at Becton Dickinson Biosciences, and he worked at Abbot Global Pharmaceutical Research and Development.
Bolce joins Crescendo after spending 19 years at Janssen Services.